C.K. Olsen

12 papers receiving 464 citations

C.K. Olsen's Hit Papers

Tralokinumab plus topical corticosteroids for the treatment of moderate‐to‐severe atopic dermatitis: results from the double‐blind, randomized, multicentre, placebo‐controlled phase III ECZTRA 3 trial* 2020 · 224 citations
2240+2+4Years since publication50100150200

Peers

C.K. Olsen
Comparison fields: 5 of 61
  • Dermatology 310
  • Immunology and Allergy 161
  • Biological Psychiatry 18
  • Rheumatology 61
  • Pharmacology 59
Replace Katharine Long with:
Katharine Long United States
Goele Bosmans Belgium
Nicole E. Kramer United States
Olga Bednarska Sweden
Helena C. Brigas Portugal
Slavica Djukic Dejanovic Serbia
Gianfranco Puccio Italy
Katherine J. Zappia United States
E. Trabucco Italy
Marinella Russo Italy
C.K. Olsen relative to Katharine Long United States Katharine Long's profile →
Citations per field
00.5×20×40×61×
Katharine Long · 1×
Citations per year

Countries citing papers authored by C.K. Olsen

Since Specialization
Citations

This map shows the geographic impact of C.K. Olsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C.K. Olsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C.K. Olsen more than expected).

Fields of papers citing papers by C.K. Olsen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C.K. Olsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C.K. Olsen. The network helps show where C.K. Olsen may publish in the future.

Co-authors

The 25 scholars most cited alongside C.K. Olsen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with C.K. Olsen Line = papers co-authored together C.K. Olsen links everyone, so they are left out of the graph.

All Works

12 of 12 papers shown
#Work
1
Tralokinumab plus topical corticosteroids for the treatment of moderate‐to‐severe atopic dermatitis: results from the double‐blind, randomized, multicentre, placebo‐controlled phase III ECZTRA 3 trial*
Hit paper breakdown →
2020224
2 201775
3 202258
4 202156
5 201925
6 200221
7 20155
8 20123
9
Vortioxetine Reduces BOLD Signal during Performance of the N-Back Task in Subjects Remitted from Depression and Healthy Control Participants
20142
10 20132
11 20152
12 20151

About C.K. Olsen

C.K. Olsen is a scholar working on Pharmacology, Dermatology, Molecular Biology, Critical Care and Intensive Care Medicine and Cellular and Molecular Neuroscience, having authored 12 papers that have together received 474 indexed citations. Recurring topics across this work include Treatment of Major Depression (6 papers), Dermatology and Skin Diseases (3 papers), Anesthesia and Neurotoxicity Research (1 paper), Intensive Care Unit Cognitive Disorders (1 paper), Receptor Mechanisms and Signaling (1 paper), Neurotransmitter Receptor Influence on Behavior (1 paper), Functional Brain Connectivity Studies (1 paper) and Neuroscience and Neuropharmacology Research (1 paper). The work is most often cited by research in Dermatology (310 citations), Immunology and Allergy (161 citations), Biological Psychiatry (18 citations), Rheumatology (61 citations) and Pharmacology (59 citations). C.K. Olsen has collaborated with scholars based in Denmark, United States and United Kingdom. Frequent co-authors include Jonathan I. Silverberg, B K Bang, Stephan Weidinger, Andrew Alexis, D. Toth, DirkJan Hijnen, Azra Kurbasic, Andrew Pink, Boni E. Elewski and Thomas Bieber. Their work appears in journals such as European Neuropsychopharmacology, British Journal of Dermatology, Journal of Affective Disorders, Behavioural Pharmacology and Neuropsychopharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact